Uncategorized
Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too.
Bill Harris, a veteran Los Angeles photojournalist, didn’t think much of it when one morning in 2012 he woke up and found a tiny blood spot on the T-shirt he’d slept in. The next morning, he found blood in the same place on his chest — and went straight to his computer.
“Online, I could find only three things that would cause a man’s nipple to discharge blood: being an avid runner, which I wasn’t; having a subtropical fungus, which I didn’t; and breast cancer,” he said. “That was a pretty big shock.”
Harris, then just a few weeks shy of his 61st birthday, immediately called his doctor, who ordered a mammogram and ultrasound. They confirmed a cancerous growth in his right breast. Ten days later, a biopsy came back positive. The next month Harris got a right mastectomy, followed by the removal of his left breast half a year later.
“I walked into a woman’s imaging center and had to get into a pink paper robe,” he recalled. “All the women in the waiting room were staring at me.”
Like many other Ashkenazi men, Harris never had considered that he might have been born with a harmful mutation of the BRCA gene, which elevates the risk not only of breast cancer, but also of melanoma and prostate, ovarian and pancreatic cancer.
“Hundreds of other mutations in the BRCA gene are just as dangerous, but they’re not specific to Ashkenazim,” said Dr. Robert Sidlow, director of the Male BRCA Genetic Risk Program at New York’s Memorial Sloan Kettering Cancer Center. About 1 in 40 Ashkenazi Jews (those of Eastern European descent) carries the harmful mutation, compared to about 1 in 400 in the general population.
“The vast majority of patients I see are relatives of women who have breast or ovarian cancer and then get tested,” he said. Of BRCA mutation carriers, Sidlow added, “Most men are pretty happy to enroll in some kind of surveillance program once they get over the initial shock.”
Sidlow is on the Men’s Leadership Council at Sharsheret, the national Jewish nonprofit organization that educates the community about cancer risks and supports those with breast cancer and ovarian cancer.
Elana Silber, CEO of Sharsheret (Hebrew for “chain”), says it’s crucial that men with a family history of cancer undergo genetic counseling screening for BRCA and other hereditary cancer mutations.
Genetic testing is possible via a standard blood or saliva sample.
While Sharsheret is primarily considered a women’s organization, it has been using November — nicknamed Movember for its focus on men’s health — for an awareness campaign focused on Jewish men’s cancer risks.
“This is not only a women’s issue,” Silber said. “Family history is so important. When a man shares his family history with his doctor, he may not realize that he should mention that his mother had breast cancer or that his sister had ovarian cancer, as these are not generally ‘men’s diseases.’ They are not aware that these cancers could mean that they themselves are at increased risk for cancer and that they can pass on these mutations to the next generation – their daughters and their sons.”
If someone discovers he (or she) is a carrier of one of the genetic mutations with elevated cancer risks — not just BRCA but also such mutations as ATM, TP53, CHEK2, and PALB2 — there are various precautions they can take for themselves and their children. They can monitor their own health more closely, they can get encourage their children to test to see if they are carriers and, for any future children, take steps to prevent the mutated genes from being passed down.
For example, couples can conceive via in vitro fertilization, or IVF, and then test the embryos before implantation to ensure that only those unaffected by the genetic mutation are implanted.
While most women are aware of the risks of breast cancer, men generally are not — even though the disease strikes 2,500 men in the U.S. every year and kills about 500 of them, according to Sidlow. About 1-2% of men with the BRCA1 mutation and 6-7% of men with the BRCA2 mutation will develop cancer by age 80.
“This is why we recommend periodic mammograms starting at about age 50 for men who carry a BRCA2 mutation,” Sidlow said. “We like to educate these men on how to check their chests once a month and have a clinician do a breast checkup on them once a year.”
Since the BRCA1 and BRCA2 mutations also make prostate cancer more likely, men with either mutation should get PSA (prostate-specific antigen) levels in their blood tested annually beginning at age 40, rather than 50, the age at which screening generally begins, Sidlow said.
Sharsheret has been promoting the importance of learning one’s family history, genetic counseling and screening among both men and women. The 20-year-old organization also runs various peer support networks, offers financial assistance to cancer patients, provides mental health counseling and guidance to patients, caregivers, and their friends, and seeks to educate the broader Jewish community about cancer risks and support.
Peggy Cottrell, a certified genetic counselor at Sharsheret, said men in general are more reluctant to get regular checkups than women.
Ashkenazi Jewish men are at elevated risk not just of breast and prostate cancer but also of pancreatic cancer. Pancreatic cancer is particularly difficult because it’s tough to detect early enough and hard to treat. The five-year survival rate is only 11%. About 2% of BRCA1 carriers and 4% of BRCA2 carriers will develop pancreatic cancer, Sidlow estimated.
“Usually by the time pancreas cancer is clinically detected it has already spread microscopically to the liver,” Sidlow said. “But pancreas cancer is potentially curable if caught when the tumor is extremely small.”
Even among those with elevated risks, certain behaviors can improve one’s odds, such as avoiding obesity, smoking and excessive alcohol consumption.
Harris, the California photojournalist, is still fighting at age 71. While he overcame breast cancer 10 years ago, last year he was diagnosed with ampullary cancer, a rare disease related to his BRCA2 status that was discovered thanks to his participation in a UCLA study. Surgeons have removed his gall bladder, half his pancreas and part of his small intestine, and he has had to endure eight rounds of chemotherapy.
“I’m still working through the aftereffects of the chemo. I have to eat smaller quantities than before and take enzymes to supplement my digestive processes,” Harris said.
Meanwhile, his 37-year-old son discovered that he, too, carries the BRCA2 mutation, and he had a double prophylactic mastectomy and reconstruction at age 30 — just to be on the safe side.
“If there’s any history of breast, ovarian or prostate cancer in your family, get tested genetically so that you’re informed,” Harris advised. “Diagnoses happen way too late for men, and the danger is too big.”
—
The post Hereditary cancers aren’t just a women’s problem. Jewish men need to take precautions too. appeared first on Jewish Telegraphic Agency.
Uncategorized
UCLA student government condemns campus Hillel for hosting former hostage
A campus event featuring freed Israeli hostage Omer Shem Tov drew the condemnation of UCLA’s student government on Tuesday. In an open letter, the UCLA Students Associated Council said that bringing Tov to speak to students “served to legitimize and normalize” atrocities in Gaza and Lebanon.
Shem Tov, 23, was kidnapped from the Nova music festival in Southern Israel on Oct. 7, 2023, and held hostage in Gaza until his release in a prisoner exchange in February 2025. UCLA hosted him on April 14 for a Yom HaShoah event.
“While we affirm the humanity of all people impacted by violence, we reject the selective platforming of narratives that obscure the broader reality of ongoing state violence,” the student government letter wrote in the letter, which was addressed to the UCLA administration and UCLA Hillel among others. “Israel is currently continuing to carry out what has been widely identified by human rights advocates as a genocide in Gaza, while also expanding its illegal military campaign into Lebanon.
“In this context, elevating a single narrative, absent of critical political and humanitarian framing, serves to legitimize and normalize these ongoing atrocities.”
Rabbi Chaim Seidler-Feller, UCLA Hillel’s director emeritus, called the statement “completely ridiculous.”
“You can’t present the narrative of your experience without it being called ‘one sided,’” Seidler-Feller said. “There has to be a counter-story to persecution. Is there a counter-story to killing people?”
UCLA Hillel executive director Daniel Gold dismissed the criticism in Tuesday’s letter as antisemitic.
“Hillel at UCLA and Students Supporting Israel UCLA would like to apologize…for absolutely nothing,” he wrote in a statement. “Members of UCLA student government have once again shown they are anti-dialogue, anti-learning, anti-truth, anti-student and antisemitic.”
The USAC did not respond to a request for comment.
As college campuses across the country became a hotspot for pro-Palestinian activism following the Oct. 7 attack, UCLA, with an activist history and a large Jewish population, stood out as a major flashpoint. Its student encampment was the site of a riot in April 2024 and eventually cleared by police in riot gear.
The USAC has sided with pro-Palestinian protesters throughout. In a Feb. 2025 letter titled “We Are All SJP,” the USAC, which is democratically elected by the roughly 30,000-member UCLA student body, condemned Chancellor Julio Frenk’s suspension of Students for Justice in Palestine. The letter referred to Israel only as “the Zionist state” or put the country’s name inside quotation marks.
The University of California has since been sued by the Department of Justice, which said that UCLA created a hostile work environment against Jewish and Israeli faculty in violation of Title VII of the Civil Rights Act.
The post UCLA student government condemns campus Hillel for hosting former hostage appeared first on The Forward.
Uncategorized
Trump extends ceasefire with Iran, even after Iran balks at new round of negotiations
(JTA) — President Donald Trump announced on Tuesday that he would unilaterally extend the U.S.-Israeli ceasefire with Iran, even though Iran had not agreed to his conditions or even to return to the negotiating table.
Trump announced the decision on Truth Social just hours before the two-week-old deal was set to expire. Citing Iran’s “fractured” leadership, Trump wrote that he had been asked by Pakistani Prime Minister Shehbaz Sharif to “hold our Attack on the Country of Iran until such time as their leaders and representatives can come up with a unified proposal.”
Vice President JD Vance’s planned trip to Islamabad, where talks were set to take place, was postponed indefinitely after Iran failed to confirm its participation in negotiations.
Trump added that the United States would maintain its naval blockade of Iranian ports in the Strait of Hormuz, despite Iran’s repeated calls for the restrictions to be lifted.
The announcement marked a sharp departure from the president’s statements earlier in the day, telling CNBC that, if a deal was not made before the deadline, “I expect to be bombing.”
In a statement Tuesday, Sharif thanked Trump for his “gracious acceptance” of Pakistan’s request to extend the ceasefire, adding that the country would “continue its earnest efforts for a negotiated settlement of the conflict.”
The announcement adds to uncertain about the war’s future, including for Israelis who lived through six weeks of Iranian bombing, and renews questions about Trump’s commitment to achieving his war goals, which have varied and included blunting Iran’s nuclear ambitions, achieving regime change, and destroying Iran’s stockpile of ballistic missiles. He said earlier this week that he was asking Iran to limit its nuclear program for 20 years, five years longer than was required by the deal struck by Barack Obama in 2015. Trump exited that deal in 2018.
Last week, Trump announced a different ceasefire, between Israel and Lebanon, on Truth Social, contradicting Israel’s claim that the Iran ceasefire would not apply to its fighting with Hezbollah, an Iran-backed proxy in Lebanon.
Trump’s announcement of the ceasefire extension came during the night in Israel, after Israelis began their celebration of Independence Day. It drew criticism from one of his staunchest pro-Israel supporters, the Zionist Organization of America, whose national president Morton Klein said in a statement that “interminable delay is the standard Islamic Iranian regime negotiating tactic” and that acceding to it represented a victory for Iran. The statement did not mention Trump.
The post Trump extends ceasefire with Iran, even after Iran balks at new round of negotiations appeared first on The Forward.
Uncategorized
Alan Dershowitz quits Democratic Party, calling it ‘most anti-Israel party in U.S. history’
(JTA) — Alan Dershowitz, the prominent pro-Israel attorney whose clients have included Donald Trump and Jeffrey Epstein, announced on Monday that he was leaving the Democratic party and registering as a Republican.
Describing himself as a “lifelong Democrat,” Dershowitz wrote in a Wall Street Journal op-ed that he had decided to “bite the bullet and register as a Republican,” citing Democratic support for an arms embargo on Israel last week and the Michigan Senate candidate Abdul el-Sayed’s anti-Israel rhetoric.
“There is no denying that the hard left, anti-Israel wing of the Democratic Party has moved from the fringe to the mainstream,” Dershowitz wrote, adding that “Republicans have their own antisemitic fringe, but for now it remains a fringe.”
The announcement formalized a political evolution for Dershowitz, who defended Trump during his first impeachment and has increasingly broken with Democrats over Israel in recent years.
In 2021, Dershowitz nominated Jared Kushner, Trump’s son-in-law, and Avi Berkowitz, Trump’s top Middle Eastern envoy during his first administration, for the Nobel Peace Prize over their hand in shaping the Abraham Accords.
Dershowitz — who has recently faced scrutiny over his ties to Epstein, and previously denied allegations of sexual misconduct made by one of Epstein’s accusers — panned the Democratic Party as the “most anti-Israel party in U.S. history” in the op-ed.
“I believe that the Democratic Party’s hostility to Israel represents a deeper and more dangerous shift away from the center and toward a radical approach that is bad for America and the free world,” Dershowitz wrote, adding that he intended to “work hard to prevent the Democrats from gaining control of the House and Senate.”
Dershowitz’s comments are in line with Trump’s statements about Jews and the Democratic Party. He has repeatedly expressed amazement at how any Jews could vote for the Democrats considering his own record when it comes to Israel.
The post Alan Dershowitz quits Democratic Party, calling it ‘most anti-Israel party in U.S. history’ appeared first on The Forward.